Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Core Viewpoint - Glucotrack, Inc. has announced a public offering of approximately 2.6 million shares of common stock at a price of $1.15 per share, aiming to raise approximately$3.0 million before expenses [1][2]. Company Overview - Glucotrack, Inc. is a medical technology company focused on developing novel technologies for diabetes management, including a long-term implantable continuous blood glucose monitoring system [5][6]. Offering Details - The public offering is being conducted under a registration statement declared effective by the SEC on October 3, 2024, and is expected to close on or about February 5, 2025, pending customary closing conditions [3][1]. - Dawson James Securities, Inc. is acting as the sole placement agent for this public offering [2].